ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology ASLAN PHARMACEUTICALS LIMITEDMay 5, 2021 GMT - ASLAN will give a poster presentation of new data from its Single Ascending Dose (SAD) study of ASLAN004, during the virtual event on 6 May, 2021 SINGAPORE, May 05, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today ...